Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HURRAH: Adalimumab for Bone Erosion Healing in RA
NCT00696059Phase 4Completed
- Sponsor
- Copenhagen University Hospital - Hvidovre
- Start
- Aug 2004
- Primary completion
- Jul 2007
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab in rheumatoid arthritis (RA), sponsored by Copenhagen University Hospital - Hvidovre. Started Aug 2004; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00696059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00696059.